Inflammatory bowel disease in patients with psoriasis treated with interleukin-17 inhibitors

• Main Authors: Keira A Fieldhouse (Author), Samantha Ukaibe (Author), Erika L Crowley (Author), Reena Khanna (Author), Ashley O'Toole (Author), Melinda J Gooderham (Author)
• Format: Book
• Published: BioExcel Publishing Ltd, 2020-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Interleukin 17 (IL-17) inhibitors provide an excellent treatment option for patients with psoriasis and psoriatic arthritis, resulting in high levels of efficacy for skin clearance and joint improvement. Safety has also been established in clinical trials for this group of biologic agent...